MedPath

Clinical observation of Zhuangdan Yanshi Decoction combined with dapoxetine in the treatment of premature ejaculatio

Phase 1
Conditions
Premature Ejaculation
Registration Number
ITMCTR2100005426
Lead Sponsor
Shaanxi Provincial Hospital of Traditional Chinese Medicin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

(1) Meet the diagnostic criteria of Western medicine for premature ejaculation;
(2) Syndrome differentiation is biliary depression and phlegm disturbance;
(3) 18=age=64 years old, the course of disease is more than 1 month;
(3) The patient has a regular sex partner and has regular sex lives, and the number of sex lives =4 times per month;
(4) Intravaginal ejaculation latency (IELT) <3 min
(5) Volunteer to participate in this research.

Exclusion Criteria

? Subjective PE, variability PE;
?Patients with erectile dysfunction (IIEF-5 score =21 points);
?Patients suffering from important diseases such as heart, liver, kidney, diabetes, and hyperthyroidism;
?Patients with urogenital diseases such as prostatitis and urethritis;
? Congenital developmental abnormalities of the reproductive system;
?Persons who have taken other PE drugs within 4 weeks or who have taken other drugs that affect ejaculation;
?Patients with mental illness and HADS=8 points;
? Those who have had a family plan in the past 6 months;
? Others who are not suitable for inclusion in the research.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IELT;Premature Ejaculation Efficacy Evaluation Scale;
Secondary Outcome Measures
NameTimeMethod
PEP;CIPE-5;PEDT;
© Copyright 2025. All Rights Reserved by MedPath